QuikReader

QuikReader

  • Latest
  • Top stories
  • Business
  • Tech
  • World
  • Politics
  • Sports
  • Lifestyle
  • Health
  • Science
  • Entertainment
  • More
    • Sources
Sign in

Latest in Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction

Sort by
1,920 items

  • Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction

    Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company's multiple sclerosis products.
    Business - CNBC - October 30

  • Biogen’s stock hit by soft sales of Alzheimer’s treatment

    “We continue to see momentum with ongoing product launches and we are increasingly excited about the potential of our pipeline,” the company’s CEO said.
    Business - MarketWatch - October 30

  • Sony raises guidance on gaming strength, quarterly operating profit beats estimates

    Sony raised sales guidance for the full year and posted operating profit that smashed analyst expectations after a strong quarter for its gaming business.
    Business - CNBC - November 8

  • Bristol Myers’s stock pops as earnings top estimates and company raises guidance

    The company says it “made important strides in the third quarter.”
    Business - MarketWatch - October 31

  • Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance

    Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.
    Business - CNBC - October 30

  • Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug

    Biogen’s stock rose 1% Thursday, after Europe’s pharmaceutical regulator issued a positive opinion on the Alzheimer’s disease drug that the company developed with Japanese partner Eisai — reversing ...
    Business - MarketWatch - 6 days ago

  • Pfizer’s earnings crush estimates as company raises guidance

    Drug company Pfizer saw strong growth for its heart-disease drugs and migraine treatment.
    Business - MarketWatch - October 29

  • Far right gains traction in EU assembly

    Patriots and ultraconservatives push centre-right EPP away from its allies
    World - Financial Times - 11 hours ago

  • Telia Raises Guidance After Key Metric Profit Beat

    The Swedish telecommunications operator said it expected stronger growth momentum in the fourth quarter of the year and raised its guidance as it reported a slight beat on adjusted underlying ...
    Business - The Wall Street Journal - October 24
  • Commerzbank Lifts Guidance as UniCredit Circles

    Commerzbank Lifts Guidance as UniCredit Circles

    Commerzbank lifted its full-year guidance for some key metrics and said its strategy is paying off, as UniCredit continued to signal interest in a tie-up with the German lender.
    Business - The Wall Street Journal - November 6

  • Southwest Airlines profit tops estimates, company expects higher revenue in fourth quarter

    Southwest said travel demand remains healthy and it expects unit revenue for the fourth quarter to grow 3.5% to 5.5%.
    Business - CNBC - October 24

  • Lowe’s CEO confident in retailer’s ability to manage Trump tariffs after earnings beat

    “We feel good about the processes and the systems we put in place since the first Trump administration, to manage tariffs,” said Lowe’s CEO Marvin R. Ellison
    Business - MarketWatch - 2 days ago

  • Danske Bank Lifts Guidance After Net Profit Tops Hopes

    The Copenhagen-based bank raised its full-year net profit forecast after reporting a market-beating figure for the third quarter.
    Business - The Wall Street Journal - October 31

  • E.l.f. shares soar as cosmetics retailer raises guidance after posting 40% sales gain

    E.l.f. Beauty raised its full year guidance after posting a 40% jump in sales.
    Business - CNBC - November 6

  • Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales

    It is a critical quarterly report for Pfizer, which is grappling with activist pressure from Starboard Value.
    Business - CNBC - October 29

  • Peloton raises its full-year profit guidance, but expects the holiday quarter to be softer than expected

    Peloton's cash flows are improving, but it's expecting to sell fewer bikes and treadmills during its holiday quarter than Wall Street expected.
    Business - CNBC - October 31

  • Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall

    The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business.
    Business - CNBC - October 31

  • Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs

    The pharmaceutical giant also raised its full-year revenue forecast to an increase of roughly 5%.
    Business - CNBC - October 31
  • NHS will not fund new drug to slow Alzheimer’s

    NHS will not fund new drug to slow Alzheimer’s

    A new drug that slows the pace of Alzheimer's disease is too expensive for too little benefit to be used on the NHS, the watchdog says.
    Top stories - BBC News - October 23
  • Chancellor and BoE governor call for UK to rebuild ties with EU

    Chancellor and BoE governor call for UK to rebuild ties with EU

    Reeves and Bailey highlight damage from Brexit amid concern about Trump’s plan to impose tariffs on trading partners
    Business - Financial Times - 6 days ago
  • Britain’s bold plan to create super funds

    Britain’s bold plan to create super funds

    The case for consolidating the UK’s sprawling pension arsenal is strong
    Business - Financial Times - 6 days ago

  • Papa John’s stock falls as same-store sales hurt by still-cash-strapped consumer

    Pizza chain says it’s still operating in a challenging consumer environment.
    Business - MarketWatch - November 7
  • Disney Q4 bolstered by strong results from streaming, 'Inside Out 2' and 'Deadpool & Wolverine'

    Disney Q4 bolstered by strong results from streaming, 'Inside Out 2' and 'Deadpool & Wolverine'

    Disney’s fourth-quarter adjusted profit beat Wall Street’s expectations, bolstered by strong results from its streaming service and box office success with “Inside Out 2” and “Deadpool & Wolverine.”
    Tech - ABC News - November 14

  • Carvana raises 2024 earnings guidance after topping Wall Street's Q3 expectations

    Carvana said its adjusted EBITDA would be "significantly above the high end" of its previous target of $1 billion to $1.2 billion.
    Business - CNBC - October 30

  • GM stock has best day since 2020 after automaker tops Wall Street's third-quarter expectations, raises guidance

    GM's quarterly report comes just two weeks after an investor day in which the company indicated its earnings strength is expected to continue into next year.
    Business - CNBC - October 22
  • UK regulator approves second Alzheimer's drug in months but government won't pay for it

    UK regulator approves second Alzheimer's drug in months but government won't pay for it

    Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after an independent watchdog agency said the treatment isn’t worth the cost ...
    Health - ABC News - October 23
  • UK regulator approves second Alzheimer's drug in months but government won't pay for it

    UK regulator approves second Alzheimer's drug in months but government won't pay for it

    Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after an independent watchdog agency said the treatment isn’t worth the cost ...
    World - ABC News - October 23
  • UK borrowing costs hit post-election high on eve of Reeves’ first Budget

    UK borrowing costs hit post-election high on eve of Reeves’ first Budget

    Chancellor will draw parallels with Tony Blair government’s efforts to repair country’s social fabric in late 1990s
    Business - Financial Times - October 30

  • Spectrum Brands’ stock slides as profit lags estimates

    “Challenging economic and geopolitical conditions” are impacting consumer demand, according to its CEO.
    Business - MarketWatch - 6 days ago
  • Kuaishou Posts Profit, Revenue Growth, Meeting Estimates

    Kuaishou Posts Profit, Revenue Growth, Meeting Estimates

    The Chinese short-video app operator reported in-line results on advertising strength, even as it continued to face challenges in its e-commerce business.
    Business - The Wall Street Journal - Yesterday

  • Klarna IPO emerges as fintechs gain traction and bankers signal more interest in stock debuts

    The buy-now-pay-later company aims to tap into a revival of interest in stocks like Affirm and SoFi.
    Business - MarketWatch - November 13
  • 1
  • 2
  • 3
  • »
  Follow topic
Topics
  • Biogen Tops Estimates
  • Tops Estimates Raises
  • Estimates Raises Profit
  • Raises Profit Guidance
  • Profit Guidance Alzheimer's
© 2024 QuikReader - About - Terms - Privacy